XermeloActive Ingredient(s): Telotristat Ethyl
FDA Approved: * February 28, 2017
Pharm Company: * LEXICON PHARMA INC
Telotristat ethyl (USAN, brand name Xermelo) is a prodrug of telotristat, which is an inhibitor of tryptophan hydroxylase. It is formulated as telotristat etiprate — a hippurate salt of telotristat ethyl. On February 28, 2017, the U.S. Food and Drug Administration (FDA) approved telotristat ethyl in combination with somatostatin analog (SSA) therapy for the treatment of adults with diarrhea associated with carcinoid syndrome that SSA therapy alone has inadequately con... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.